HC Wainwright & Co. Downgrades Adicet Bio to Neutral
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has downgraded Adicet Bio (NASDAQ:ACET) from Buy to Neutral, as per analyst Edward White.
September 11, 2024 | 10:18 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
HC Wainwright & Co. has downgraded Adicet Bio from Buy to Neutral, which may indicate a less optimistic outlook on the company's stock performance.
The downgrade from Buy to Neutral by a reputable analyst firm suggests a shift in sentiment, potentially leading to a negative short-term impact on the stock price as investors may reassess their positions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100